Precancerous niche remodelling dictates nascent tumour persistence

Interactions between mutant cells and their environment have a key role in determining cancer susceptibility<sup>1-3</sup>. However, understanding of how the precancerous microenvironment contributes to early tumorigenesis remains limited. Here we show that newly emerging tumours at their most incipient stages shape their microenvironment in a critical process that determines their survival. Analysis of nascent squamous tumours in the upper gastrointestinal tract of the mouse reveals that the stress response of early tumour cells instructs the underlying mesenchyme to form a supportive 'precancerous niche', which dictates the long-term outcome of epithelial lesions. Stimulated fibroblasts beneath emerging tumours activate a wound-healing response that triggers a marked remodelling of the underlying extracellular matrix, resulting in the formation of a fibronectin-rich stromal scaffold that promotes tumour growth. Functional heterotypic 3D culture assays and in vivo grafting experiments, combining carcinogen-free healthy epithelium and tumour-derived stroma, demonstrate that the precancerous niche alone is sufficient to confer tumour properties to normal epithelial cells. We propose a model in which both mutations and the stromal response to genetic stress together define the likelihood of early tumours to persist and progress towards more advanced disease stages.

Authors

Institutions

Publication Details

Journal
Nature
Published
2026-03-04
DOI
https://doi.org/10.1038/s41586-026-10157-8
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Precancerous niche remodelling dictates nascent tumour persistence

J. E. Rojo Arias, G. Skrupskelyte, W. Knight, M. T. Bejar et al.
Nature
Cancer Cells and Metastasis
article

Precancerous niche remodelling dictates nascent tumour persistence

J. E. Rojo Arias, G. Skrupskelyte, W. Knight, M. T. Bejar, B. D. Simons, D. Aust, K. Murai, J. C. Fowler, A. Noorani, P. H. Jones, S. Han, S. Zeki, H. Ajith, M. K. S. Tang, Y. Dang, M. P. Alcolea, J. Jászai, S. Rulands, M. H. H. Schmidt, B. Colom, D. Rossetti
article en

Abstract

Interactions between mutant cells and their environment have a key role in determining cancer susceptibility<sup>1-3</sup>. However, understanding of how the precancerous microenvironment contributes to early tumorigenesis remains limited. Here we show that newly emerging tumours at their most incipient stages shape their microenvironment in a critical process that determines their survival. Analysis of nascent squamous tumours in the upper gastrointestinal tract of the mouse reveals that the stress response of early tumour cells instructs the underlying mesenchyme to form a supportive 'precancerous niche', which dictates the long-term outcome of epithelial lesions. Stimulated fibroblasts beneath emerging tumours activate a wound-healing response that triggers a marked remodelling of the underlying extracellular matrix, resulting in the formation of a fibronectin-rich stromal scaffold that promotes tumour growth. Functional heterotypic 3D culture assays and in vivo grafting experiments, combining carcinogen-free healthy epithelium and tumour-derived stroma, demonstrate that the precancerous niche alone is sufficient to confer tumour properties to normal epithelial cells. We propose a model in which both mutations and the stromal response to genetic stress together define the likelihood of early tumours to persist and progress towards more advanced disease stages.

Nature
St Thomas' Hospital (GB), RHI Magnesita (Switzerland) (CH), Wellcome/MRC Cambridge Stem Cell Institute (GB), University of Cambridge (GB), The Gurdon Institute (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), Center for Theoretical Physics (PL), Hutchison/MRC Research Centre (GB), Max Planck Institute for the Physics of Complex Systems (DE), Stem Cell Institute (PA), Center for Systems Biology Dresden (DE), Addenbrooke's Hospital (GB), Max Planck Institute of Molecular Cell Biology and Genetics (DE), University Hospital Carl Gustav Carus (DE), Technische Universität Dresden (DE), Ludwig-Maximilians-Universität München (DE)
Openalex Percentile: Top 33%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.